Strategies to Enhance Antibody Affinity and Specificity Through Protein Engineering

Monoclonal antibodies (mAbs) have revolutionized modern medicine, particularly in oncology, autoimmune diseases, and infectious disease...

Engineering Antibodies with Extended Half-Life for Long-Term Therapeutic Efficacy and Safety

Therapeutic monoclonal antibodies (mAbs) have revolutionized the treatment of a wide range of diseases, including...